| 注册
首页|期刊导航|中国实用内科杂志|吸入皮质激素与茶碱控释剂或β2激动剂长期联合治疗慢性中度哮喘的研究

吸入皮质激素与茶碱控释剂或β2激动剂长期联合治疗慢性中度哮喘的研究

郭雪君 万欢英 李庆云 项轶 黄绍光 邓伟吾

中国实用内科杂志2001,Vol.21Issue(3):141-142,2.
中国实用内科杂志2001,Vol.21Issue(3):141-142,2.

吸入皮质激素与茶碱控释剂或β2激动剂长期联合治疗慢性中度哮喘的研究

Treatment of chronic moderate asthma by corticosteroid inhalation with controlled released theophylline or beta2-agonist

郭雪君 1万欢英 1李庆云 1项轶 1黄绍光 1邓伟吾1

作者信息

  • 1. 上海第二医科大学附属瑞金医院呼吸科,
  • 折叠

摘要

Abstract

Objective To investigate the efficacy of combining corticosteroid inhalation with controlled-released theophylline or beta2-agonist to chronic moderate asthmatics.Method 99 chronic moderate asthmatics were divided randomly into two groups.Patients in treatment group were given inhaled becliomethnsone and oral controlled-released theophylline.Patients in controlled group were given inhaled becliomethnsone and oral beta2-agonist.Each course was 8weeks.Frequency of asthma attack、clinic symptom score and peak expiratory flow(PEF)were taken everyday.FVC and FEF1 were measured before treatment and every two weeks after treatment.Results Frequency of asthma attack、clinic symptom score and pulmonary function were improved significantly after treatment in both groups,but there was no difference in the above observed index between the two groups.The different value of the PEF(△PEF)between the first week and the sixth as well as eighth week in treatment group was higher than that in controlled group.Conclusion The treatment of inhaled corticosteroid combing with controlled-released theophylline or beta2-agonist can decrease frequencey of asthma attack,improve the clinic symptoms and the pulmonary function.Treatment of inhaled corticosteroid combining with controlled-released theophylline can decrease △PEF more significantly than that combing with beta2agonist.

关键词

哮喘/皮质激素/吸入/氨茶碱/β2激动剂

分类

医药卫生

引用本文复制引用

郭雪君,万欢英,李庆云,项轶,黄绍光,邓伟吾..吸入皮质激素与茶碱控释剂或β2激动剂长期联合治疗慢性中度哮喘的研究[J].中国实用内科杂志,2001,21(3):141-142,2.

中国实用内科杂志

OA北大核心CSCD

1005-2194

访问量0
|
下载量0
段落导航相关论文